Abbott Laboratories (ABT) ROE: History & Chart

Abbott Laboratories(ABT)

Medical - Devices · Abbott Park, IL

$105.52-2.81 (-2.59%)

At close: Sep 8, 2026 (market close, ET)

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

115,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

ABT Return on Equity (ROE) Metrics

RETURN ON EQUITY (ROE)

10.61%

RETURN ON EQUITY (ROE) AVG TTM

18.05%

RETURN ON EQUITY (ROE) AVG 3Y

17.82%

RETURN ON EQUITY (ROE) AVG 5Y

18.73%

RETURN ON EQUITY (ROE) AVG 10Y

13.48%

RETURN ON EQUITY (ROE) AVG 15Y

14.65%

RETURN ON EQUITY (ROE) AVG 20Y

16.29%

CURRENT VS TTM AVG

-41.20%

CURRENT VS 3Y AVG

-40.43%

CURRENT VS 5Y AVG

-43.32%

CURRENT VS 10Y AVG

-21.29%

CURRENT VS 15Y AVG

-27.56%

CURRENT VS 20Y AVG

-34.86%

SECTOR MEDIAN · HEALTHCARE

13.25%

median of 83 covered companies

CURRENT VS SECTOR MEDIAN

-19.89%

vs the sector median at left

NAME	MARKET CAP	RETURN ON EQUITY (ROE)	TTM	3Y	5Y
Abbott Laboratories (ABT)	$182.59B	10.61%	18.05%	17.82%	18.73%
Gilead Sciences, Inc. (GILD)vs ›	$182.06B	-27.39%	19.98%	21.60%	19.44%
Novo Nordisk A/S (NVO)vs ›	$200.54B	53.50%	61.58%	67.05%	123.42%
Pfizer Inc. (PFE)vs ›	$158.39B	5.09%	9.04%	13.32%	16.07%
Amgen Inc. (AMGN)vs ›	$212.20B	74.80%	79.33%	111.35%	101.76%
Danaher Corporation (DHR)vs ›	$144.25B	7.61%	7.38%	9.51%	10.24%
Thermo Fisher Scientific Inc. (TMO)vs ›	$224.09B	13.25%	12.70%	13.51%	15.24%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$134.24B	21.76%	8.96%	15.60%	19.47%
Bristol-Myers Squibb Company (BMY)vs ›	$132.14B	41.59%	-8.30%	7.76%	4.45%
Intuitive Surgical, Inc. (ISRG)vs ›	$123.70B	17.28%	15.07%	13.91%	13.46%

NAME

MARKET CAP

RETURN ON EQUITY (ROE)

TTM

Abbott Laboratories (ABT)

$182.59B

10.61%

18.05%

17.82%

18.73%

Gilead Sciences, Inc. (GILD)vs ›

$182.06B

-27.39%

19.98%

21.60%

19.44%

Novo Nordisk A/S (NVO)vs ›

$200.54B

53.50%

61.58%

67.05%

123.42%

Pfizer Inc. (PFE)vs ›

$158.39B

5.09%

9.04%

13.32%

16.07%

Amgen Inc. (AMGN)vs ›

$212.20B

74.80%

79.33%

111.35%

101.76%

Danaher Corporation (DHR)vs ›

$144.25B

7.61%

7.38%

9.51%

10.24%

Thermo Fisher Scientific Inc. (TMO)vs ›

$224.09B

13.25%

12.70%

13.51%

15.24%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$134.24B

21.76%

8.96%

15.60%

19.47%

Bristol-Myers Squibb Company (BMY)vs ›

$132.14B

41.59%

-8.30%

7.76%

4.45%

Intuitive Surgical, Inc. (ISRG)vs ›

$123.70B

17.28%

15.07%

13.91%

13.46%

Return on Equity (ROE) FAQ

What is the return on equity (ROE) for Abbott Laboratories (ABT)?

The return on equity (ROE) for ABT stock is 10.61%.

Is Abbott Laboratories's return on equity (ROE) high or low?

The return on equity (ROE) of 10.61% is 43% below its 5-year average of 18.73%, near the low end of its 5-year range (10.61%–28.12%).

What is the TTM average return on equity (ROE) for Abbott Laboratories (ABT)?

The TTM average return on equity (ROE) for ABT stock is 18.05%.

What is the 3Y average return on equity (ROE) for Abbott Laboratories (ABT)?

The 3Y average return on equity (ROE) for ABT stock is 17.82%.

What is the 5Y average return on equity (ROE) for Abbott Laboratories (ABT)?

The 5Y average return on equity (ROE) for ABT stock is 18.73%.

What is the 10Y average return on equity (ROE) for Abbott Laboratories (ABT)?

The 10Y average return on equity (ROE) for ABT stock is 13.48%.

What is the 15Y average return on equity (ROE) for Abbott Laboratories (ABT)?

The 15Y average return on equity (ROE) for ABT stock is 14.65%.

What is the 20Y average return on equity (ROE) for Abbott Laboratories (ABT)?

The 20Y average return on equity (ROE) for ABT stock is 16.29%.

DATE	RETURN ON EQUITY (ROE)
2026-06-30	10.61%
2026-03-31	12.06%
2025-12-31	12.51%
2025-09-30	27.43%
2025-06-30	27.65%
2025-03-31	27.66%
2024-12-31	28.12%
2024-09-30	14.49%
2024-06-30	14.13%
2024-03-31	14.51%
2023-12-31	14.83%
2023-09-30	13.77%
2023-06-30	13.88%
2023-03-31	15.68%
2022-12-31	18.90%
2022-09-30	22.11%
2022-06-30	23.44%
2022-03-31	21.82%
2021-12-31	19.75%
2021-09-30	21.04%
2021-06-30	18.86%
2021-03-31	17.06%
2020-12-31	13.71%
2020-09-30	10.78%
2020-06-30	10.17%
2020-03-31	11.84%
2019-12-31	11.86%
2019-09-30	10.35%
2019-06-30	9.14%
2019-03-31	8.48%
2018-12-31	7.76%
2018-09-30	2.89%
2018-06-30	3.03%
2018-03-31	1.52%
2017-12-31	1.54%
2017-09-30	6.57%
2017-06-30	3.71%
2017-03-31	4.79%
2016-12-31	6.82%
2016-09-30	6.59%
2016-06-30	11.02%
2016-03-31	11.81%
2015-12-31	20.85%
2015-09-30	21.60%
2015-06-30	19.64%
2015-03-31	19.20%
2014-12-31	10.61%
2014-09-30	8.60%
2014-06-30	10.15%
2014-03-31	10.29%
2013-12-31	10.23%
2013-09-30	12.83%
2013-06-30	17.98%
2013-03-31	23.31%
2012-12-31	22.32%
2012-09-30	24.17%
2012-06-30	19.96%
2012-03-31	20.06%
2011-12-31	19.35%
2011-09-30	18.50%
2011-06-30	19.48%
2011-03-31	18.22%
2010-12-31	20.66%
2010-09-30	22.07%
2010-06-30	26.69%
2010-03-31	25.46%
2009-12-31	25.14%
2009-09-30	26.92%
2009-06-30	26.90%
2009-03-31	29.99%
2008-12-31	27.92%
2008-09-30	23.51%
2008-06-30	22.05%
2008-03-31	21.39%
2007-12-31	20.28%
2007-09-30	12.35%
2007-06-30	12.56%
2007-03-31	10.82%
2006-12-31	12.22%
2006-09-30	20.27%
2006-06-30	20.64%
2006-03-31	23.54%
2005-12-31	23.39%
2005-09-30	23.63%
2005-06-30	24.29%
2005-03-31	22.93%
2004-12-31	22.59%
2004-09-30	24.74%
2004-06-30	24.66%
2004-03-31	20.54%
2003-12-31	21.06%
2003-09-30	20.53%
2003-06-30	20.14%

DATE

RETURN ON EQUITY (ROE)

2026-06-30

10.61%

2026-03-31

12.06%

2025-12-31

12.51%

2025-09-30

27.43%

2025-06-30

27.65%

2025-03-31

27.66%

2024-12-31

28.12%

2024-09-30

14.49%

2024-06-30

14.13%

2024-03-31

14.51%

2023-12-31

14.83%

2023-09-30

13.77%

2023-06-30

13.88%

2023-03-31

15.68%

2022-12-31

18.90%

2022-09-30

22.11%

2022-06-30

23.44%

2022-03-31

21.82%

2021-12-31

19.75%

2021-09-30

21.04%

2021-06-30

18.86%

2021-03-31

17.06%

2020-12-31

13.71%

2020-09-30

10.78%

2020-06-30

10.17%

2020-03-31

11.84%

2019-12-31

11.86%

2019-09-30

10.35%

2019-06-30

9.14%

2019-03-31

8.48%

2018-12-31

7.76%

2018-09-30

2.89%

2018-06-30

3.03%

2018-03-31

1.52%

2017-12-31

1.54%

2017-09-30

6.57%

2017-06-30

3.71%

2017-03-31

4.79%

2016-12-31

6.82%

2016-09-30

6.59%

2016-06-30

11.02%

2016-03-31

11.81%

2015-12-31

20.85%

2015-09-30

21.60%

2015-06-30

19.64%

2015-03-31

19.20%

2014-12-31

10.61%

2014-09-30

8.60%

2014-06-30

10.15%

2014-03-31

10.29%

2013-12-31

10.23%

2013-09-30

12.83%

2013-06-30

17.98%

2013-03-31

23.31%

2012-12-31

22.32%

2012-09-30

24.17%

2012-06-30

19.96%

2012-03-31

20.06%

2011-12-31

19.35%

2011-09-30

18.50%

2011-06-30

19.48%

2011-03-31

18.22%

2010-12-31

20.66%

2010-09-30

22.07%

2010-06-30

26.69%

2010-03-31

25.46%

2009-12-31

25.14%

2009-09-30

26.92%

2009-06-30

26.90%

2009-03-31

29.99%

2008-12-31

27.92%

2008-09-30

23.51%

2008-06-30

22.05%

2008-03-31

21.39%

2007-12-31

20.28%

2007-09-30

12.35%

2007-06-30

12.56%

2007-03-31

10.82%

2006-12-31

12.22%

2006-09-30

20.27%

2006-06-30

20.64%

2006-03-31

23.54%

2005-12-31

23.39%

2005-09-30

23.63%

2005-06-30

24.29%

2005-03-31

22.93%

2004-12-31

22.59%

2004-09-30

24.74%

2004-06-30

24.66%

2004-03-31

20.54%

2003-12-31

21.06%

2003-09-30

20.53%

2003-06-30

20.14%

Return on Equity (ROE): 10.61%

ABT Return on Equity (ROE)

ABT Average Return on Equity (ROE) Chart

ABT Current vs Average Return on Equity (ROE) Chart

ABT Return on Equity (ROE) Metrics

ABT Competitors' Return on Equity (ROE)

Return Analysis

Return on Equity (ROE) Formula & Definition

Return on Equity (ROE) FAQ

ABT Return on Equity (ROE) History

Related Metrics